Thank you, Sue. I am pleased to say that we continued to deliver strong financial performance, with the Q4 results marking the 12th consecutive quarter of results in-line to ahead of expectations. Let's start with an update on how we are navigating the complexities of global supply and inflation. Building on the strong progress made last quarter in improving our Prestige service levels through expanded dual-sourcing, detailed supply and demand planning, and building of safety stock, we again improved in Q4, reaching a mid-90s service level exiting the quarter. We are confident that we'll be able to meet fiscal '24 demand, including during the peak holiday period. Turning to the inflationary backdrop. In the fourth quarter, COGS inflation was approximately 2.1% of sales. For the full year, COGS inflation was approximately 2% of revenues. Looking to fiscal '24, while cost inflation on certain commodities such as paper and energy are easing, costs on other materials and components are still growing in large part due to labor In the first half of fiscal '24, we continue to expect COGS inflation to remain elevated, driven by the combination of delayed inflation impact based on our procurement negotiations with suppliers, as well as the capitalization of the higher COGS we've incurred in recent months, which gets released to the P&L roughly four months later. As these two factors are more timing related and the underlying inflation drivers are clearly easing, we expect a significant moderation in COGS inflation in the second half of fiscal '24. Our execution on savings, strategic revenue management and pricing is helping us to balance this inflationary impact. We are currently in the process of another round of pricing in the first quarter of fiscal '24, as we continue our portfolio transition to cleaner and more sustainable products, which in turn also drives category value growth, while also closing pricing gaps versus our competition, particularly in Consumer Beauty. I will now provide an update on our All-in-to-Win program. In Q4, we delivered savings of approximately $50 million, bringing our fiscal year '23 savings to approximately $180 million, ahead of our target of approximately $170 million in fiscal year '23. Due to our strong project pipeline, we are increasing our fiscal year '24 savings estimate to over $100 million, up from our previous target of approximately $90 million. Savings in fiscal year '24 will be driven by material value analysis, platforming savings, and structural A&CP savings amongst other projects. We continue to target $75 million of savings in fiscal year '25, reaffirming the savings target announced in Q2. In sum, having delivered over $600 million of savings life-to-date, we continue to optimize all of our processes and expenditures, thereby positioning Coty to be both flexible and fully equipped to invest in our strategic priorities And importantly, we are now in phase two of our transformation, as we put in place more enablers for sustainable growth and business acceleration across the brands and markets, supplementing our savings initiatives, which fuel profit expansion and reinvestment. Moving to our gross margin performance. Q4 adjusted gross margin of 62.8% increased by 70 basis points from last year, bringing the year-to-date adjusted gross margin to 63.9%, which is up 20 basis points year-on-year and up by a very significant 390 basis points versus two years ago. Our Q4 gross margin increase was driven by: supply chain productivity; the positive benefits from mix; and additional price increases executed at the end of Q3. These benefits to gross margin were partially offset by COGS inflation of approximately 210 basis points of sales in Q4. Despite inflation that was prevalent this year, we delivered gross margin expansion in both Q4 and fiscal year '23. Going forward, we will continue executing on our multi-pronged, multi-year gross margin attack plan, as we drive our gross margins to the mid-60%-s and beyond. I'd like to take a moment to discuss our investments in research and development. As we have transformed our business over the last three years, steadily executing on our six pillar strategy, we have been steadily reinvesting in our organizational capabilities, including R&D. In fact, our R&D investment is close to 10% higher than it was two years ago, with investments behind skincare growing substantially above these levels. We expect to step change our R&D investments in the coming years, particularly behind skincare, as we pursue our ambition to double our skincare revenues in the next few years and position skincare as a key pillar of Coty's business model. Let me now walk you through our marketing investments. In Q4, A&CP investments represented approximately 28% of sales, stable with Q3 levels and with the prior year, as we continued to support our key initiatives. This brings the fiscal year '23 A&CP level to approximately 27%, in line with our expectations and relatively stable year-over-year. As with prior quarters, our marketing spend was concentrated behind key innovations in Prestige and Consumer Beauty, as well as whitespace opportunities. Moving to our profit delivery for the quarter. Our Q4 adjusted operating income grew 61% to $105 million, with our fiscal '23 operating income expanding a strong 20% year-on-year. This delivery was particularly impressive given strong ForEx headwinds, which negatively impacted our fiscal year '23 adjusted EBITDA by over $70 million. So, Prestige and Consumer Beauty segments delivered double-digit adjusted operating income growth in Q4 and fiscal '23, with margin improvement in both businesses. As a result, our Q4 adjusted operating margin grew 220 basis points year-over-year, with fiscal year '23 margin up strongly by 170 basis points to 13.3%. Importantly, we continue to expect strong income growth and margin expansion going forward. Our Q4 adjusted EBITDA grew 25% year-over year to $165 million, with 7% growth in fiscal year '23 to $973 million. As a result, our Q4 adjusted EBITDA margin increased 90 basis points year-over year, bringing our fiscal year '23 adjusted EBITDA margin to 17.5%, up 40 basis points versus last year. Now turning to our adjusted EPS, where we reported strong momentum in the quarter. Our Q4 diluted adjusted EPS was $0.01, up $0.02 year-over-year driven by a much stronger Q4 adjusted operating income, partially offset by higher tax and interest expense. Specifically, the Q4 interest expense stepped up sequentially vs. Q3, driven by a higher cost of debt in the rising interest rate environment, as well as a $5 million increase in ForEx costs. There was no material net impact from the mark-to-market on the equity swap in the quarter. Our fiscal year '23 diluted adjusted EPS was $0.53, up 89% year-over-year and includes a non-cash EPS benefit of $0.15 from the mark-to-market on the equity swap in the second and third quarters. Our fiscal year '23 operational EPS, excluding the swap, was $0.38, driven by net profit improvement, which reflects very substantial growth of 36% versus last year. Looking ahead to fiscal year '24, I would like to provide some additional details related to our current expectations for certain drivers of our adjusted EPS. First, we expect depreciation to be in the $230 million to $240 million range. Second, we anticipate net interest expense for the year to be in the mid $200 million. Third, we anticipate an adjusted effective tax rate for fiscal '24 in the mid to high 20%-s. Finally on fiscal '24 share count, we currently estimate 1% of dilution, though similar to fiscal '23, so quarterly share count will fluctuate based on GAAP anti-dilution provisions. Moving to our free cash flow. We generated free cash flow of $38 million in the quarter. For the year, we generated $403 million of free cash flow, which was in line with our expectations despite the inventory build required to increase safety stock and meet anticipated fragrance demand in the first half of fiscal year '24. In the coming years, we expect steady expansion in free cash flows. Our intent is to continue to use our strong free cash flow and opportunistic asset monetization to actively reduce our debt and advance our deleveraging agenda. Moving to our capital structure. We ended Q4 with net debt of approximately $4 billion. As a result, our leverage at the end of the quarter was around 4.1x, down from around 4.4x at the end of Q3 and consistent with our expectations. Factoring in our Wella stake, we ended the quarter with economic net debt of approximately $3 billion. We remain committed to divesting our Wella stake by calendar year '25 and as a first step in this objective, we recently entered into a binding letter of intent to sell 3.6% of our retained Wella stake for $150 million to IGF Wealth Management, subject to customary closing conditions including consent by KKR. The transaction would reflect a 4% premium to book value of Wella as of March 31. Additionally, as part of our active efforts to strengthen our balance sheet, we successfully issued $750 million of 2030 senior secured notes in July. We used the combination of these proceeds and our revolver to fully pay down our Term Loan B, resulting in approximately 85% of our total debt now being fixed rate, which is key in the current interest rate environment. Looking beyond fiscal '23, our strong continued progress on deleveraging and debt paydown support our expectation for our interest expense to steadily decline in the coming years, despite the currently rising interest rate environment. To sum up, we are confident in our next major leverage milestones, as we continue to target leverage towards 3x exiting calendar '23, approximately 2.5x exiting calendar year '24 and approximately 2x exiting calendar year '25. I will now hand it back to Sue to review our strategic progress in the quarter.